Brief: ArcticZymes Gets Funding From Innovation Norway
20/05/2020 10:23
May 20 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* ARCTICZYMES GRANTED NOK 1.65 MILLION FUNDING FROM
INNOVATION
NORWAY FOR A SAN-HQ UPSCALING PROJECT
* ARCTICZYMES HAS BEEN GRANTED UP TO NOK 1.65 MILLION FOR A
PROJECT TO INCREASE MANUFACTURING SCALE OF ITS SAN-HQ ENZYME
* SUPPLY OF SAN-HQ HAS POTENTIAL TO BE EXPANDED INTO OUR
PARTNERS
DEVELOPING VIRAL BASED VACCINES AGAINST COVID-19
* PROJECT WILL ACCELERATE ONGOING EFFORTS TO SCALE
PRODUCTION
CAPACITY AND IS ESTIMATED TO BE COMPLETED WITHIN 8-10 MONTHS
Source text for Eikon: ID:nWkr7RtYnf
Further company coverage: BIOTEC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))